AIPL1 and Retinal dystrophy: Notably, our findings align with the recent study [21], which demonstrated that young children with AIPL1-related retinal dystrophy benefited substantially from the subretinal administration of rAAV8.hRKp.AIPL1 with improved visual acuity, functional vision, and evidence of some protection against progressive retinal degeneration without serious adverse effects.